For more details on the content of report and ordering information please visit:
http://www.aarkstore.com/
The biosimilar market is presently a small segment of the pharmaceutical industry. However, in the years to come, the market for biosimilars has huge growth opportunity despite of the high entry barriers. The governments in the developed countries are desperately trying to control their national healthcare expenditure. Furthermore, the patents for several original bio drugs are expected to expire in the coming decade. These factors along with the new biosimilar guidelines by the US Food & Drug Administration are paving the path for the growth for the biosimilar market.
Biosimilars are generic version of bio drugs or off patent bio drugs, which are usually more cost effective compared to the original version of the drug. So far, Europe has been the most developed market for biosimilars. The biosimilar market in the Europe is strictly governed by European Medicines Agency (EMA).
The global biosimilar market is expected to become highly competitive in the coming years as original chemical drug makers, generic chemical drug makers, and original bio drug makers are entering into biosimilars business seeing the growth potential of the market. Within the biosimilar market, the pipeline for anti- TNF biosimilars is quite higher compared to other biosimilars.
It is expected that the market for Epoetin alpha and Insulin-glargine biosimilars will grow significantly during 2010-2015 in the developed countries, mainly driven by cost containment efforts from the US and European governments. Within the global first generation biosimilar market, the market for G-CSF biosimilar recorded huge growth in 2010 compared to the previous year.
The growth of the biosimilar market is mainly driven by rising aging population, growing healthcare expenditure, growing worldwide economy, and patent expiries of market leading bio drugs. New technologies like recombinant DNA technology, protein sequencing, protein electrophoresis, and western blotting are also expected to have a positive impact on the market. However, requirement of extensive clinical trials for obtaining approval, lower profit margins, and lower return on investments continues to challenge the attractiveness of the biosimilars market.
The report analyzes the global biosimilars market. The various drivers and challenges faced by the market are discussed in detail. The competitive landscape of the market is also highlighted and the key players are profiled with their key business strategies.
Table of Contents :
1. Biosimilars:
1.1 Overview
1.2 Differences between Biosimilars and Biobetters
1.3 Manufacturing of Bio Drugs
1.4 FDA’s Guidance on Biosimilars in the US
1.5 Present Market Conditions
2. Biosimilars Market
2.1 Worldwide Market
Market Value
Revenue Trend in Developed Countries
Product Pipeline
Market Statistics
2.2 Biotech Product Market in the US
2.3 Biosimilar Market in Europe
2.4 Bio Drug Market in Korea
3. Key Trends
3.1 Global Drug Makers Rushing to Develop Biosimilars
3.2 Urgent Requirement of Biosimilars in the US
3.3 Policies of European Government to Control Healthcare Expenditure
4. Growth Drivers
4.1 Rising Healthcare Expenditure
4.2 Rising Ageing Population
4.3 Growing Worldwide Economy
4.4 Upcoming Patent Expiries of Original Bio Drugs
5. Significant developments
5.1 Recombinant DNA Technology
5.2 Protein Sequencing Method
5.3 Protein Electrophoresis
5.4 Western Blotting
5.5 Monoclonal Antibodies (MAB) Technology
6. Challenges
6.1 Requirement of Extensive Clinical Trials for Obtaining Approval
6.2 Strong Marketing Capabilities Required
6.3 Lower Margins in Biosimilars
6.4 Concern over Return on Investments of Biosimilars
7. Biosimilars Market - Competitive Landscape
Competitive Overview
Market Share
8. Company Profile
8.1 Hospira Inc.
Business Description
Key Financials
Business Strategies
Product Development Strategy
Achieving Product Differentiation
8.2 Teva Pharmaceutical Industries Limited
Business Description
Key Financials
Business Strategies
Increasing Generic Market Share
Expanding OTC Opportunities
8.3 Merck & Co., Inc.
Business Description
Key Financials
Business Strategies
R&D Strategy
Merger Restructuring Program
8.4 Novartis AG
Business Description
Key Financials
Business Strategies
Leadership in Innovation
Driving Productivity of the Organization
9. Market Outlook
More Research Reports:
Global Biosimilars Market Report: 2012 Edition
Sports Medicine Market Report: 2012 Edition
Global Molecular Diagnostics Market Report: 2012 Edition
Generic Testing Market Report: 2012 Edition
Global Eyewear Market Report: 2012 Edition
Global Flat Glass Market Report: 2012 Edition
Global Hemophilia Market Report: 2012 Edition
Global Handbags Market Report: 2012 Edition
Global Seeds Market Report: 2012 Edition
Global Clinical Laboratory Testing Market Report: 2012 Edition
Global Cruise Market Report: 2012 Edition
Global Food Ingredients Market Report: 2012 Edition
Global Industrial Enzymes Market Report: 2012 Edition
Nutritional Supplements Market Report: 2012 Edition
Global Polyester Market Report: 2012 Edition
Global Trauma Market Report: 2012 Edition
Global Fiberglass Composite Market Report: 2012 Edition
Global Furniture Market Report: 2012 Edition
Global Paints & Coatings Market Report: 2012 Edition
Global Excavator Market Report: 2012 Edition
Global Glucose Monitoring Market Report: 2012 Edition
Global Smokeless Tobacco Market Report: 2012 Edition
Global Rubber Gloves Market: An Analysis
Cardiac Rhythm Management (CRM) Market Report: 2011 Edition
Global ATM Market Report: 2011 Edition
Global Blood Plasma Market Report: 2011 Edition
Global Heart Valve Market Report: 2011 Edition
Global Baby Food Market Report: 2011 Edition
Indian Micro Irrigation System Industry: 2011 Edition
Global Endoscopy Market Report: 2011 Edition
Global Polysilicon Market Report: 2011 Edition
Global Money Transfer (Remittances)
Global Crop Protection (Pesticides)
Global Sugar & Sweeteners Market Report - 2011 Edition
Global Intravenous (IV) Iron Drugs Market: 2011 Edition
Global Animal Health Market Report: 2011 Edition
Global Contract Catering Market Report – 2011 Edition
Global Palm Oil Market Report: 2011 Edition
Global Dental Market Report: 2011 Edition
Global Metallic Silicon Market: An Analysis
Global Flavor & Fragrance Market Report – 2011 Edition
Global Car Sharing Market Report: 2011 Edition
Global Leisure Boat Market Report: 2011 Edition
Indian Aesthetic (Cosmetic) Surgery Market: 2011 Edition
Indonesia:
Singapore:
Thailand:
Global Hydroprocessing Catalyst (HPC) Market: An Analysis
